A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial)
Clinical trial NCT06129539 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06129539
- Sponsor
- Debiopharm International SA
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2026-10-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.